J.P. Duffy reflects on international arbitration in the life sciences industry throughout 2021, exploring the increase in emergency arbitration and uptick in manufacturing and distribution disputes, before looking ahead to what 2022 might bring, including the potential proliferation of disputes linked to M&A and expert determination.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
